Money Info Investment News Show

MONEY INFO SHOW 

INVESTMENT NEWS SHOW

Thursdays 6:05 PM To 7:00 PM EDT

MEDICAL STOCK NEWS

Watch a replay of the show:

LISTEN LIVE Use this Link To Watch The Next Show:

http://www.ustream.tv/channel/wpsl-the-talk-of-the-treasure-coast%21

BE ON THE AIR WITH US
CALL IN YOUR QUESTIONS
888-792-1590

The show featured:

Terry Howlett, President and CEO of Skinvisible, Inc.

Stock Symbol: SKVI

Get SKVI Stock Quote and Trading Charts: http://finance.yahoo.com/q?s=SKVI

Corporate Site: www.Skinvisible.com

Product Site: www.Invisicare.com

Recent News

Skinvisible Granted US Patent for Stabilizing Retinoids

Intellectual Property Portfolio Strengthens

See full release: http://finance.yahoo.com/news/skinvisible-granted-us-patent-stabilizing-194548557.html

See More SKVI News: http://www.skinvisible.com/press/index.html

Skinvisible Pharmaceuticals, Inc. (subsidiary of Skinvisible, Inc.), is a pharmaceutical R&D company that researches and develops enhanced patented dermatology and healthcare products using its Invisicare® technology. These products which are applied to the skin have the ability to last for four hours, resisting wash-off and rub-off. Invisicare® is the delivery system that delivers water-soluble and certain cationic active ingredients to the skin without the use of alcohol, waxes, silicones and other organic solvents.

Skinvisible has developed a pipeline of 30+ products includes prescription, over-the-counter and cosmeceutical formulations to treat conditions from acne to warts, along with sunscreens, anti-aging products, hand sanitizing lotions, and pre-surgical preparations. Skinvisible also provides “life-cycle management” to companies seeking extended patent protection along with enhanced product features and benefits.

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

Money Info is hosted by Mike King, Charles Moskowitz and Oscar Carboni.

Be the first to comment

Leave a Reply